Johnson & Johnson Current Assets
Johnson & Johnson (JNJ) had Current Assets of $59.77 billion as of 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-23
- 2026-06-28: Assets, Current $59.77B.
- 2026-03-29: Assets, Current $59.17B.
- 2025-12-28: Assets, Current $55.62B.
- 2025-09-28: Assets, Current $54.61B.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-28 | $59.77B 10-Q · filed 2026-07-23 | |
| 2026-03-29 | $59.17B 10-Q · filed 2026-04-22 | |
| 2025-12-28 | $55.62B 10-Q · filed 2026-07-23 | |
| 2025-09-28 | $54.61B 10-Q · filed 2025-10-22 | |
| 2025-06-29 | $54.50B 10-Q · filed 2025-07-24 | |
| 2025-03-30 | $71.55B 10-Q · filed 2025-04-23 | |
| 2024-12-29 | $55.89B 10-K · filed 2026-02-11 | |
| 2024-09-29 | $53.25B 10-Q · filed 2024-10-23 | |
| 2024-06-30 | $57.82B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $57.00B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $53.49B 10-K · filed 2025-02-13 | |
| 2023-10-01 | $53.70B 10-Q · filed 2023-10-27 | |
| 2023-07-02 | $60.57B 10-Q · filed 2023-07-31 | |
| 2023-04-02 | $64.39B 10-Q · filed 2023-04-28 | |
| 2023-01-01 | $55.29B 10-K · filed 2024-02-16 | |
| 2022-10-02 | $65.24B 10-Q · filed 2022-10-27 | |
| 2022-07-03 | $63.85B 10-Q · filed 2022-07-29 | |
| 2022-04-03 | $60.42B 10-Q · filed 2022-04-29 | |
| 2022-01-02 | $60.98B 10-K · filed 2023-02-16 | |
| 2021-10-03 | $59.89B 10-Q · filed 2021-10-29 | |
| 2021-07-04 | $53.77B 10-Q · filed 2021-07-29 | |
| 2021-04-04 | $52.53B 10-Q · filed 2021-04-30 | |
| 2021-01-03 | $51.24B 10-K · filed 2022-02-17 | |
| 2020-09-27 | $57.58B 10-Q · filed 2020-10-23 | |
| 2020-06-28 | $45.89B 10-Q · filed 2020-07-24 | |
| 2020-03-29 | $44.23B 10-Q · filed 2020-04-29 | |
| 2019-12-29 | $45.27B 10-K · filed 2021-02-22 | |
| 2019-09-29 | $44.33B 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $41.80B 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $41.99B 10-Q · filed 2019-05-01 | |
| 2018-12-30 | $46.03B 10-K · filed 2020-02-18 | |
| 2018-09-30 | $47.19B 10-Q · filed 2018-10-31 | |
| 2018-07-01 | $45.44B 10-Q · filed 2018-08-02 | |
| 2018-04-01 | $42.77B 10-Q · filed 2018-05-01 | |
| 2017-12-31 | $43.09B 10-K · filed 2019-02-20 | |
| 2017-10-01 | $41.83B 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $38.79B 10-Q · filed 2017-08-03 | |
| 2017-04-02 | $63.35B 10-Q · filed 2017-05-08 | |
| 2017-01-01 | $65.03B 10-K · filed 2018-02-21 | |
| 2016-10-02 | $63.32B 10-Q · filed 2016-11-04 | |
| 2016-07-03 | $66.29B 10-Q · filed 2016-08-04 | |
| 2016-04-03 | $62.74B 10-Q · filed 2016-05-10 | |
| 2016-01-03 | $60.21B 10-K · filed 2017-02-27 | |
| 2015-09-27 | $63.49B 10-Q · filed 2015-10-30 | |
| 2015-06-28 | $61.00B 10-Q · filed 2015-07-31 | |
| 2015-03-29 | $58.19B 10-Q · filed 2015-05-01 | |
| 2014-12-28 | $55.74B 10-K · filed 2016-02-24 | $59.31B 10-K · filed 2015-02-24 |
| 2014-09-28 | $59.97B 10-Q · filed 2014-10-30 | |
| 2014-06-29 | $60.12B 10-Q · filed 2014-08-01 | |
| 2014-03-30 | $57.37B 10-Q · filed 2014-05-02 | |
| 2013-12-29 | $56.41B 10-K · filed 2015-02-24 | |
| 2013-09-29 | $52.18B 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $51.27B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $47.23B 10-Q · filed 2013-05-03 | |
| 2012-12-30 | $46.12B 10-K · filed 2014-02-21 | |
| 2012-09-30 | $44.79B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $41.62B 10-Q · filed 2012-08-02 | |
| 2012-04-01 | $57.01B 10-Q · filed 2012-05-07 | |
| 2012-01-01 | $54.32B 10-K · filed 2013-02-22 | |
| 2011-10-02 | $53.44B 10-Q · filed 2011-11-08 | |
| 2011-07-03 | $52.67B 10-Q · filed 2011-08-09 | |
| 2011-04-03 | $49.22B 10-Q · filed 2011-05-10 | |
| 2011-01-02 | $47.31B 10-K · filed 2012-02-23 | |
| 2010-10-03 | $42.72B 10-Q · filed 2010-11-10 | |
| 2010-07-04 | $39.02B 10-Q · filed 2010-08-11 | |
| 2010-04-04 | $38.86B 10-Q · filed 2010-05-10 | |
| 2010-01-03 | $39.54B 10-K · filed 2011-02-25 | |
| 2009-09-27 | $35.60B 10-Q · filed 2009-11-04 | |
| 2009-06-28 | $35.49B 10-Q · filed 2009-08-04 | |
| 2008-12-28 | $34.38B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |